MEDS · DataMEDS AI, Inc.

Wellgistics Health has terminated its Settlement Agreement with Silverback Capital, which was originally established on January 28, 2026. This agreement had contemplated the issuance of common stock under Section 3(a)(10) of the Securities Act, and prior to termination, the company had already issued 6,866,000 shares. The termination eliminates any potential future dilution that would have occurred through additional share issuances under this arrangement. As part of the termination, Silverback Capital has been requested to return all rights to any unpaid claims back to the applicable creditors. The company states that this move allows it to pursue alternative strategic and financing initiatives, suggesting a shift in its capital structure approach. Both parties are now released from all obligations under the agreement, providing the company with greater flexibility in its future financing decisions.